No matter how one views it, the age of Artificial Intelligence (AI) is upon us, and the medical field will benefit as much as any field.
Look at the TV beer ad for Carlsberg, a Danish brewer, what use to take them years in coming up with new, improved flavors is now done in a matter of seconds to a few minutes. It also tells them what yeasts will do well in large scale production vs only small brew lots. Thus, they sell those that can't be mass-produced to small brewers and target for themselves only those that will adapt well to large scale production.
AI fits in so well with the many variables in the human body and the need for a drug to work well, or at least not hinder, with these variables that the speed of coming up with new drugs is going to be amazing and I wouldn't be surprised to see the FDA accept computerized models as the basis for clinical trial results down the road.
Defensin protein mimetics (DPM) IMO are simply the first of AI drugs synthesized way, way ahead of their time. That is why the creators are so confident that they will perform as expected in current trials and why I feel Brilacidin is going to excel in a gangbuster amount of various indications. It was not developed thru a haphazard trial and error method in a small lab but instead was developed using supercomputer analysis that allowed it to be crafted near ideally. Better drug, safer drug due to technology. Wonder what it would be worth to a BP just to be able to get their hands on the full details of manufacturing a DPM and the creation of one? IMO would be extremely valuable to their in-house product development efforts.
Look at the TV beer ad for Carlsberg, a Danish brewer, what use to take them years in coming up with new, improved flavors is now done in a matter of seconds to a few minutes. It also tells them what yeasts will do well in large scale production vs only small brew lots. Thus, they sell those that can't be mass-produced to small brewers and target for themselves only those that will adapt well to large scale production.
AI fits in so well with the many variables in the human body and the need for a drug to work well, or at least not hinder, with these variables that the speed of coming up with new drugs is going to be amazing and I wouldn't be surprised to see the FDA accept computerized models as the basis for clinical trial results down the road.
Defensin protein mimetics (DPM) IMO are simply the first of AI drugs synthesized way, way ahead of their time. That is why the creators are so confident that they will perform as expected in current trials and why I feel Brilacidin is going to excel in a gangbuster amount of various indications. It was not developed thru a haphazard trial and error method in a small lab but instead was developed using supercomputer analysis that allowed it to be crafted near ideally. Better drug, safer drug due to technology. Wonder what it would be worth to a BP just to be able to get their hands on the full details of manufacturing a DPM and the creation of one? IMO would be extremely valuable to their in-house product development efforts.
9
